Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Larson

Showing results (711-720 of 798) with videos related to

Pageof 80
Sort By:
Medrxiv : the Preprint Server for Health Sciences|December 25, 2025
Meta-analysis of genome-wide association studies of doxorubicin-induced arrhythmia identifies <i>MMP16</i> and <i>KCTD15</i> as risk lociJoseph S Reddy, Milagros Pereyra, Mohammed Tiseer Abbas, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 7, 2020
A Distinct Transcriptional Program in Human CAR T Cells Bearing the 4-1BB Signaling Domain Revealed by scRNA-SeqAngela C Boroughs, Rebecca C Larson, Nemanja D Marjanovic, et al.
American Journal of Obstetrics and Gynecology|November 13, 2013
Menopausal quality of life: RCT of yoga, exercise, and omega-3 supplementsSusan D Reed, Katherine A Guthrie, Katherine M Newton, et al.
Haematologica|November 30, 2023
Matching-adjusted indirect comparison from the Lymphoma Epidemiology of Outcomes Consortium for Real World Evidence (LEO CReWE) study to a clinical trial of mosunetuzumab in relapsed or refractory follicular lymphomaMatthew J Maurer, Carla Casulo, Melissa C Larson, et al.
Scientific Reports|February 8, 2014
Clinical characteristics of ovarian cancer classified by BRCA1, BRCA2, and RAD51C statusJ M Cunningham, M S Cicek, N B Larson, et al.
Molecular Cancer|October 7, 2024
Proapoptotic activity of JNK-sensitive BH3-only proteins underpins ovarian cancer response to replication checkpoint inhibitorsAnnapoorna Venkatachalam, Cristina Correia, Kevin L Peterson, et al.
Leukemia|March 7, 2020
Targeting of inflammatory pathways with R2CHOP in high-risk DLBCLKeenan T Hartert, Kerstin Wenzl, Jordan E Krull, et al.
Cell Reports. Medicine|March 1, 2024
Follicular lymphoma B cells exhibit heterogeneous transcriptional states with associated somatic alterations and tumor microenvironmentsJordan E Krull, Kerstin Wenzl, Melissa A Hopper, et al.
Blood Advances|November 27, 2024
Treatment patterns and outcomes in follicular lymphoma with POD24: an analysis from the LEO ConsortiumJonathan R Day, Melissa C Larson, Urshila Durani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2019
Chimeric Antigen Receptor T Cells Targeting CD79b Show Efficacy in Lymphoma with or without Cotargeting CD19Maria Ormhøj, Irene Scarfò, Maria L Cabral, et al.
Pageof 80

Showing results (711-720 of 798) with videos related to

Sort By:
Pageof 80
Medrxiv : the Preprint Server for Health Sciences|December 25, 2025
Meta-analysis of genome-wide association studies of doxorubicin-induced arrhythmia identifies <i>MMP16</i> and <i>KCTD15</i> as risk lociJoseph S Reddy, Milagros Pereyra, Mohammed Tiseer Abbas, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 7, 2020
A Distinct Transcriptional Program in Human CAR T Cells Bearing the 4-1BB Signaling Domain Revealed by scRNA-SeqAngela C Boroughs, Rebecca C Larson, Nemanja D Marjanovic, et al.
American Journal of Obstetrics and Gynecology|November 13, 2013
Menopausal quality of life: RCT of yoga, exercise, and omega-3 supplementsSusan D Reed, Katherine A Guthrie, Katherine M Newton, et al.
Haematologica|November 30, 2023
Matching-adjusted indirect comparison from the Lymphoma Epidemiology of Outcomes Consortium for Real World Evidence (LEO CReWE) study to a clinical trial of mosunetuzumab in relapsed or refractory follicular lymphomaMatthew J Maurer, Carla Casulo, Melissa C Larson, et al.
Scientific Reports|February 8, 2014
Clinical characteristics of ovarian cancer classified by BRCA1, BRCA2, and RAD51C statusJ M Cunningham, M S Cicek, N B Larson, et al.
Molecular Cancer|October 7, 2024
Proapoptotic activity of JNK-sensitive BH3-only proteins underpins ovarian cancer response to replication checkpoint inhibitorsAnnapoorna Venkatachalam, Cristina Correia, Kevin L Peterson, et al.
Leukemia|March 7, 2020
Targeting of inflammatory pathways with R2CHOP in high-risk DLBCLKeenan T Hartert, Kerstin Wenzl, Jordan E Krull, et al.
Cell Reports. Medicine|March 1, 2024
Follicular lymphoma B cells exhibit heterogeneous transcriptional states with associated somatic alterations and tumor microenvironmentsJordan E Krull, Kerstin Wenzl, Melissa A Hopper, et al.
Blood Advances|November 27, 2024
Treatment patterns and outcomes in follicular lymphoma with POD24: an analysis from the LEO ConsortiumJonathan R Day, Melissa C Larson, Urshila Durani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2019
Chimeric Antigen Receptor T Cells Targeting CD79b Show Efficacy in Lymphoma with or without Cotargeting CD19Maria Ormhøj, Irene Scarfò, Maria L Cabral, et al.
Pageof 80